Literature DB >> 31315998

Complement-Mediated Neutralization of a Potent Neurotropic Human Pathogen, Chandipura Virus, Is Dependent on C1q.

Umerali Kunnakkadan1,2, Joydeep Nag1,3, Nisha Asok Kumar1,3, Reshma Koolaparambil Mukesh1,3, Sreenath Muraleedharan Suma1, John Bernet Johnson4.   

Abstract

Among the innate immune sentinels, the complement system is a formidable first line of defense against pathogens, including viruses. Chandipura virus (CHPV), a neurotropic vesiculovirus of the family Rhabdoviridae, is a deadly human pathogen known to cause fatal encephalitis, especially among children. The nature of interaction and the effect of human complement on CHPV are unknown. Here, we report that CHPV is a potent activator of complement and, thus, is highly sensitive to complement proteins in normal human serum (NHS). Utilizing a panel of specific complement component depleted/reconstituted human serum, we have demonstrated that CHPV neutralization is C3, C4, and C1q dependent and independent of factor B, suggesting the importance of the classical pathway in limiting CHPV. Employing a range of biochemical approaches, we showed (i) a direct association of C1q to CHPV, (ii) deposition of complement proteins C3b, C4b, and C1q on CHPV, and (iii) virus aggregation. Depletion of C8, an important component of the pore-forming complex of complement, had no effect on CHPV, further supporting the finding that aggregation and not virolysis is the mechanism of virus neutralization. With no approved vaccines or treatment modalities in place against CHPV, insights into such interactions can be exploited to develop potent vaccines or therapeutics targeting CHPV.IMPORTANCE Chandipura virus is a clinically important human pathogen of the Indian subcontinent. The rapidity of death associated with CHPV infection in addition to the absence of an effective vaccine or therapeutics results in poor clinical prognosis. The biology of the virus and its interaction with the host immune system, including the complement system, are understudied. Our investigation reveals the susceptibility of CHPV to fluid phase complement and also dissects the pathway involved and the mechanism of virus neutralization. Direct binding of C1q, an important upstream component of the classical pathway of complement to CHPV, and the strong dependency on C1q for virus neutralization highlight the significance of identifying such interactions to better understand CHPV pathogenesis and devise strategies to target this deadly pathogen.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Chandipura virus; aggregation; complement; complement C1q; virus neutralization

Mesh:

Substances:

Year:  2019        PMID: 31315998      PMCID: PMC6744236          DOI: 10.1128/JVI.00994-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates.

Authors:  B P Morgan
Journal:  Methods Mol Biol       Date:  2000

Review 3.  Complement: a unique innate immune sensor for danger signals.

Authors:  Philippe Gasque
Journal:  Mol Immunol       Date:  2004-11       Impact factor: 4.407

Review 4.  The complement system in regulation of adaptive immunity.

Authors:  Michael C Carroll
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

Review 5.  Emerging patterns in complement-mediated pathogen recognition.

Authors:  Ramon Roozendaal; Michael C Carroll
Journal:  Cell       Date:  2006-04-07       Impact factor: 41.582

6.  Cold activation of serum complement in patients with chronic hepatitis C: study on activating pathway and involvement of IgG.

Authors:  Y Ishii; H Shimomura; M Itoh; M Miyake; F Ikeda; J Miyaike; S Fujioka; Y Iwasaki; H Tsuji; T Tsuji
Journal:  Acta Med Okayama       Date:  2001-08       Impact factor: 0.892

7.  Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.

Authors:  Manfred Kopf; Brian Abel; Awen Gallimore; Michael Carroll; Martin F Bachmann
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

8.  Mannan-binding lectin modulates the response to HSV-2 infection.

Authors:  M Gadjeva; S R Paludan; S Thiel; V Slavov; M Ruseva; K Eriksson; G-B Löwhagen; L Shi; K Takahashi; A Ezekowitz; J C Jensenius
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

9.  Protective immune responses against West Nile virus are primed by distinct complement activation pathways.

Authors:  Erin Mehlhop; Michael S Diamond
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

Review 10.  Viral mimicry of the complement system.

Authors:  John Bernet; Jayati Mullick; Akhilesh K Singh; Arvind Sahu
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

View more
  6 in total

1.  C1q Regulates Horizontal Cell Neurite Confinement in the Outer Retina.

Authors:  Courtney A Burger; Danye Jiang; Fenge Li; Melanie A Samuel
Journal:  Front Neural Circuits       Date:  2020-10-16       Impact factor: 3.492

Review 2.  In the Crosshairs: RNA Viruses OR Complement?

Authors:  Nisha Asok Kumar; Umerali Kunnakkadan; Sabu Thomas; John Bernet Johnson
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

3.  Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.

Authors:  Jack Mellors; Tom Tipton; Sarah Katharina Fehling; Joseph Akoi Bore; Fara Raymond Koundouno; Yper Hall; Jacob Hudson; Frances Alexander; Stephanie Longet; Stephen Taylor; Andrew Gorringe; N'Faly Magassouba; Mandy Kader Konde; Julian Hiscox; Thomas Strecker; Miles Carroll
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

Review 4.  Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.

Authors:  Jack Mellors; Tom Tipton; Stephanie Longet; Miles Carroll
Journal:  Front Immunol       Date:  2020-07-09       Impact factor: 7.561

Review 5.  Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses.

Authors:  Valarmathy Murugaiah; Praveen M Varghese; Nazar Beirag; Syreeta De Cordova; Robert B Sim; Uday Kishore
Journal:  Viruses       Date:  2021-05-02       Impact factor: 5.048

6.  Human C1q Regulates Influenza A Virus Infection and Inflammatory Response via Its Globular Domain.

Authors:  Praveen M Varghese; Uday Kishore; Reena Rajkumari
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.